Table 3.
The Survival rate of CC Patients
Factors | Survival rate (95% CI) | ||
---|---|---|---|
1-year | 5-year | 10-year | |
Overall | 77.36 (75.46 - 79.14) | 49.29 (46.98 - 51.55) | 43.16 (40.71 - 45.59) |
Age at diagnosis | |||
<30 | 60.84 (40.40 - 76.15) | 48.26 (28.39 - 65.61) | 43.44 (23.96 - 61.47) |
30-49 | 78.97 (75.90 - 81.70) | 54.71 (50.95 - 58.30) | 51.87 (47.97 - 55.61) |
50-59 | 79.58 (76.09 - 82.62) | 53.11 (48.83 - 57.20) | 46.00 (41.44 - 50.43) |
≥60 | 73.98 (70.32 - 77.27) | 39.21 (35.18 - 43.21) | 29.73 (25.44 - 34.12) |
Health insurance | |||
Civil servant medical benefit scheme | 92.81 (90.43 - 94.62) | 80.58 (77.03 - 83.65) | 79.14 (75.38 - 82.39) |
Social security scheme | 85.42 (76.62 - 91.09) | 57.48 (46.59 - 66.93) | 55.74 (44.65 - 65.46) |
Universal health coverage scheme | 69.64 (67.06 - 72.07) | 34.55 (31.86 - 37.25) | 26.24 (23.52 - 29.03) |
Stage | |||
Stage I | 97.57 (94.67 - 98.90) | 91.84 (87.49 - 94.72) | 87.85 (82.23 - 91.78) |
Stage II | 83.89 (79.71 - 87.28) | 55.37 (49.96 - 60.44) | 50.00 (44.42 - 55.32) |
Stage III | 81.26 (78.44 - 83.74) | 46.07 (42.47 - 49.59) | 36.69 (32.74 - 40.64) |
Stage IV | 57.49 (53.19 - 61.55) | 29.92 (25.91 - 34.02) | 25.41 (21.01 - 30.04) |
Histopathology | |||
Squamous cell carcinoma | 79.39 (77.12 - 81.46) | 50.39 (47.57 - 53.14) | 44.46 (41.49 - 47.38) |
Adenocarcinoma | 74.94 (70.28 - 78.98) | 48.50 (43.23 - 53.56) | 41.07 (35.32 - 46.72) |
Malignant neoplasms | 66.02 (57.66 - 73.11) | 46.17 (37.36 - 54.51) | 39.39 (30.18 - 48.46) |
Others | 76.11 (67.79 - 82.55) | 44.26 (35.09 - 53.04) | 40.64 (31.43 - 49.65) |
Treatment | |||
Surgery | 92.89 (88.49 - 95.65) | 85.84 (80.25 - 89.94) | 81.22 (74.47 - 86.35) |
Concurrent chemoradiotherapy | 86.63 (83.48 - 89.22) | 53.33 (48.76 - 57.68) | 42.72 (37.07 - 48.24) |
Surgery + chemotherapy | 86.36 (63.44 - 95.39) | 57.55 (34.07 - 75.31) | 51.80 (28.64 - 70.75) |
Surgery + radiotherapy + chemotherapy | 83.09 (74.78 - 88.86) | 54.51 (44.69 - 63.30) | 50.39 (40.57 - 59.14) |
Surgery + radiotherapy | 82.22 (72.63 - 88.71) | 59.16 (48.12 - 68.61) | 53.14 (41.76 - 63.27) |
Radiotherapy | 73.73 (69.62 - 77.38) | 39.23 (34.77 - 43.66) | 32.44 (28.00 - 36.94) |
Chemotherapy | 65.27 (50.19 - 76.79) | 36.32 (22.64 - 50.13) | - |
Supportive care | 61.63 (57.04 - 65.89) | 36.13 (31.56 - 40.71) | 32.14 (27.30 - 37.06) |
Others, Sarcoma, Carcinosarcoma, and Melanoma; CI, Confidence interval